Emera Inc: Barclays cuts target price to $50 from $53
EMA•Barclays cut its target price for Emera Inc to $50 from $53.
Related News

Ideaya Biosciences and Servier announce data from three uveal melanoma trials at ESMO 2026
IDYA•

Madison Air Solutions: Stifel cuts target price to $35 from $41
MAIR•

Parabilis Medicines to present updated zolucatetide trial data in desmoid tumors at ESMO 2026
PBLS•

Silgan partners with AIP to acquire Trivium
SLGN•

Hudson Pacific Properties: BMO cuts target price to $13 from $14
HPP•